https://marketwirenews.com Market Wire News RSS News Feed for Intellia Therapeutics Inc. (NASDAQ: NTLA) Wed, 07 Oct 2026 13:19:34 -0400 en-US hourly 60 https://marketwirenews.com/assets/img/icons/favicon-32x32.png https://marketwirenews.com 32 32 https://marketwirenews.com/newsletter/ Wed, 07 Oct 2026 13:19:34 -0400 https://marketwirenews.com/newsletter/?v=1229 https://marketwirenews.com/trending-stocks/ Wed, 07 Oct 2026 13:19:34 -0400 https://marketwirenews.com/trending-stocks/?v=1229 https://marketwirenews.com/advertise/ Wed, 07 Oct 2026 13:19:34 -0400 https://marketwirenews.com/advertise/?v=1229 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-reports-additional-positive-ph-5877936675677202.html?utm_source=rss-news-releases Sat, 13 Jun 2026 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-reports-additional-positive-ph-5877936675677202.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-report-additional-phase-3-h-4509868974026858.html?utm_source=rss-news-releases Mon, 01 Jun 2026 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-report-additional-phase-3-h-4509868974026858.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-quarter-2026-f-4958033475573698.html?utm_source=rss-news-releases Mon, 11 May 2026 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-quarter-2026-f-4958033475573698.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-pricing-of-public-of-6610454142790785.html?utm_source=rss-news-releases Wed, 29 Apr 2026 07:00:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-pricing-of-public-of-6610454142790785.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-announces-proposed-public-offering-of-commo-7382728658834172.html?utm_source=rss-news-releases Mon, 27 Apr 2026 16:01:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-announces-proposed-public-offering-of-commo-7382728658834172.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-reports-positive-phase-3-resul-7777995678934821.html?utm_source=rss-news-releases Mon, 27 Apr 2026 07:00:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-reports-positive-phase-3-resul-7777995678934821.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-initiates-rolling-submission-o-4864390078678754.html?utm_source=rss-news-releases Mon, 27 Apr 2026 07:00:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-initiates-rolling-submission-o-4864390078678754.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-report-topline-data-from-gl-6699735611331083.html?utm_source=rss-news-releases Fri, 24 Apr 2026 16:05:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-report-topline-data-from-gl-6699735611331083.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/the-credibility-filter-wall-street-uses-to-sort-biot-8836298379945218.html?utm_source=rss-news-releases Wed, 08 Apr 2026 09:15:00 -0400 https://marketwirenews.com/stock/ntla/news/the-credibility-filter-wall-street-uses-to-sort-biot-8836298379945218.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-presents-longer-term-clinical--7509721144629537.html?utm_source=rss-news-releases Tue, 03 Mar 2026 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-presents-longer-term-clinical--7509721144629537.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fda-lift-of-clinical-4769885767611499.html?utm_source=rss-news-releases Mon, 02 Mar 2026 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fda-lift-of-clinical-4769885767611499.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fourth-quarter-and-f-8171773030280459.html?utm_source=rss-news-releases Thu, 26 Feb 2026 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fourth-quarter-and-f-8171773030280459.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-participate-in-upcoming-inv-8848829885393153.html?utm_source=rss-news-releases Tue, 24 Feb 2026 08:00:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-participate-in-upcoming-inv-8848829885393153.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-to-dis-5118404712180981.html?utm_source=rss-news-releases Thu, 19 Feb 2026 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-to-dis-5118404712180981.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fda-lift-of-clinical-4716812098419856.html?utm_source=rss-news-releases Tue, 27 Jan 2026 08:00:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fda-lift-of-clinical-4716812098419856.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-present-at-the-44th-annual--7803816674551348.html?utm_source=rss-news-releases Wed, 07 Jan 2026 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-present-at-the-44th-annual--7803816674551348.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-presents-positive-longer-term--6112763579360285.html?utm_source=rss-news-releases Mon, 10 Nov 2025 15:17:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-presents-positive-longer-term--6112763579360285.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-presents-positive-pooled-phase-8063496407791690.html?utm_source=rss-news-releases Sat, 08 Nov 2025 17:13:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-presents-positive-pooled-phase-8063496407791690.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-third-quarter-2025-f-6804312859171882.html?utm_source=rss-news-releases Thu, 06 Nov 2025 16:00:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-third-quarter-2025-f-6804312859171882.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-stock-alert-securities-investi-6021420187459127.html?utm_source=rss-news-releases Mon, 27 Oct 2025 09:41:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-stock-alert-securities-investi-6021420187459127.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-provides-update-on-magnitude-c-6377853237714153.html?utm_source=rss-news-releases Mon, 27 Oct 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-provides-update-on-magnitude-c-6377853237714153.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-reports-inducement-grants-unde-4523653886601790.html?utm_source=rss-news-releases Fri, 03 Oct 2025 16:01:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-reports-inducement-grants-unde-4523653886601790.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-positive-longer-term-6293479680511623.html?utm_source=rss-news-releases Thu, 25 Sep 2025 09:52:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-positive-longer-term-6293479680511623.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-present-longer-term-data-fr-6032193174990171.html?utm_source=rss-news-releases Mon, 22 Sep 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-present-longer-term-data-fr-6032193174990171.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-completes-enrollment-in-the-gl-4726247938778571.html?utm_source=rss-news-releases Thu, 18 Sep 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-completes-enrollment-in-the-gl-4726247938778571.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-second-quarter-2025--8365719744486766.html?utm_source=rss-news-releases Thu, 07 Aug 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-second-quarter-2025--8365719744486766.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-xa0-to-4908251782283818.html?utm_source=rss-news-releases Thu, 31 Jul 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-xa0-to-4908251782283818.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-positive-three-year--7354527899993176.html?utm_source=rss-news-releases Sun, 15 Jun 2025 10:45:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-positive-three-year--7354527899993176.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-announces-positive-two-year-follow-up-data--6994971158928690.html?utm_source=rss-news-releases Sun, 18 May 2025 07:25:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-announces-positive-two-year-follow-up-data--6994971158928690.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-quarter-2025-f-7781336397658639.html?utm_source=rss-news-releases Thu, 08 May 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-quarter-2025-f-7781336397658639.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-xa0-to-8081993002271239.html?utm_source=rss-news-releases Thu, 01 May 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-xa0-to-8081993002271239.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/lawsuit-for-investors-in-shares-of-intellia-therapeu-8240688699320619.html?utm_source=rss-news-releases Wed, 23 Apr 2025 09:50:00 -0400 https://marketwirenews.com/stock/ntla/news/lawsuit-for-investors-in-shares-of-intellia-therapeu-8240688699320619.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/final-deadline-today-for-the-intellia-therapeutics-i-8188241845740462.html?utm_source=rss-news-releases Mon, 14 Apr 2025 10:58:00 -0400 https://marketwirenews.com/stock/ntla/news/final-deadline-today-for-the-intellia-therapeutics-i-8188241845740462.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/final-deadline-alert-faruqi-faruqi-llp-investigates--8656383459137704.html?utm_source=rss-news-releases Mon, 14 Apr 2025 10:13:00 -0400 https://marketwirenews.com/stock/ntla/news/final-deadline-alert-faruqi-faruqi-llp-investigates--8656383459137704.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/ntla-deadline-rosen-law-firm-urges-intellia-therapeu-6312247116165600.html?utm_source=rss-news-releases Fri, 11 Apr 2025 12:02:00 -0400 https://marketwirenews.com/stock/ntla/news/ntla-deadline-rosen-law-firm-urges-intellia-therapeu-6312247116165600.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-patient-dosed--8184516782951170.html?utm_source=rss-news-releases Thu, 03 Apr 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-patient-dosed--8184516782951170.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fda-regenerative-med-6145915835526518.html?utm_source=rss-news-releases Wed, 26 Mar 2025 07:30:00 -0400 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fda-regenerative-med-6145915835526518.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/the-gross-law-firm-reminds-shareholders-of-a-lead-pl-4881301281630996.html?utm_source=rss-news-releases Thu, 06 Mar 2025 05:45:00 -0500 https://marketwirenews.com/stock/ntla/news/the-gross-law-firm-reminds-shareholders-of-a-lead-pl-4881301281630996.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/ongoing-deadline-alert-faruqi-faruqi-llp-investigate-6956761622308187.html?utm_source=rss-news-releases Tue, 04 Mar 2025 11:08:00 -0500 https://marketwirenews.com/stock/ntla/news/ongoing-deadline-alert-faruqi-faruqi-llp-investigate-6956761622308187.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fourth-quarter-and-f-8436501452947343.html?utm_source=rss-news-releases Thu, 27 Feb 2025 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-fourth-quarter-and-f-8436501452947343.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/robbins-llp-reminds-intellia-therapeutics-inc-ntla-i-4737713674081582.html?utm_source=rss-news-releases Wed, 26 Feb 2025 20:56:00 -0500 https://marketwirenews.com/stock/ntla/news/robbins-llp-reminds-intellia-therapeutics-inc-ntla-i-4737713674081582.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-inc-sued-for-securities-law-vi-5057336493503089.html?utm_source=rss-news-releases Mon, 24 Feb 2025 05:45:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-inc-sued-for-securities-law-vi-5057336493503089.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-to-dis-5807708916057243.html?utm_source=rss-news-releases Thu, 20 Feb 2025 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-to-hold-conference-call-to-dis-5807708916057243.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-inc-sued-for-securities-law-vi-8616693539573742.html?utm_source=rss-news-releases Tue, 18 Feb 2025 05:45:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-inc-sued-for-securities-law-vi-8616693539573742.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/rosen-law-firm-urges-intellia-therapeutics-inc-nasda-6255709545886744.html?utm_source=rss-news-releases Thu, 13 Feb 2025 12:29:00 -0500 https://marketwirenews.com/stock/ntla/news/rosen-law-firm-urges-intellia-therapeutics-inc-nasda-6255709545886744.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-patient-dosed--7930732842414059.html?utm_source=rss-news-releases Wed, 22 Jan 2025 07:30:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-first-patient-dosed--7930732842414059.html?s=ntla?v= https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-anticipated-2025-mil-4667260314014493.html?utm_source=rss-news-releases Thu, 09 Jan 2025 16:00:00 -0500 https://marketwirenews.com/stock/ntla/news/intellia-therapeutics-announces-anticipated-2025-mil-4667260314014493.html?s=ntla?v=